12:00 AM
 | 
Jul 30, 2012
 |  BC Week In Review  |  Company News  |  Deals

Refine Technology, Thermo Fisher, China National Pharmaceutical Group deal

Cell culture company Refine partnered with Sinopharm's Wuhan Institute of Biological Products to improve the yield and reduce the cost of vaccine manufacturing using Refine's ATF System. The ATF System is a cell retention device that uses Alternating...

Read the full 168 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >